Frank Binder

Managing Director GSCA | Global Supply Chain Advisors

Day 1 | 19th November

Pharmaceutical manufacturers significantly invest in enhanced visibility and control of their supply chains
The increased focus on speciality products and its impact on sales channels and distribution structures
The “forgotten “end” in “end-to-end”: the patient
Outlook: from a reactive to a predictive supply chain…?

Check out the incredible speaker line-up to see who will be joining Frank.